Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Genscript Corporation CLEC12A/MICL/CLL-1 His Cynom

Supplier:  Genscript Corporation Z03962100

Encompass_Preferred

CLEC12A has recently been identified as an antigen expressed on leukemic stem cells and leukemic blasts Given the fact that this expression profile seems stable throughout diagnosis treatment and relapse on leukemic blasts and leukemic stem cells CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML

Catalog No. 50-000-57928


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.